AnaptysBio, Inc. (ANAB)
NASDAQ·Healthcare·Biotechnology
$54.77
+2.01%
Mkt Cap $2.25B
Analyst Ratings
Buy
13
Hold
1
Sell
0
Price Target (31 analysts)
$73.67
Range $50.00 – $90.00
Implied Upside
+34.5%
Consensus $73.67 vs current $54.77
NASDAQ·Healthcare·Biotechnology
$54.77
+2.01%
Mkt Cap $2.25B
Buy
13
Hold
1
Sell
0
Price Target (31 analysts)
$73.67
Range $50.00 – $90.00
+34.5%
Consensus $73.67 vs current $54.77